Reinventing drug discovery

Using a new stem-cell based drug screening technology with the potential to reinvent and greatly reduce the cost of the way new pharmaceuticals are developed, Harvard Stem Cell Institute researchers have found a compound more effective in protecting the neurons killed in amyotrophic lateral sclerosis -- Lou Gehrig's disease -- than two drugs that failed in human clinical trials after hundreds of millions of dollars had been invested in them.

Read the whole article on Eurekalert

More from Eurekalert